Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...

Trump HHS ends nearly $1 billion in funding to Moderna for mRNA bird flu vaccines, citing safety concerns and lack of ...

Several mRNA vaccine trials found a debilitating side effect, and now the Trump administration is cutting funding for more ...

Moderna (MRNA) stock in focus as the U.S. FDA approved its next-gen COVID-19 vaccine, mNEXSPIKE,. Read more here.

The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...

NEXSPIKE becomes Moderna’s third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc.

A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...

With COVID cases rising in India and several other countries, many people are wondering whether they should get vaccinated.

The US government has cancelled a $590 million Moderna deal for a bird flu vaccine over safety and ethical concerns about ...

Moderna, Inc. (NASDAQ:MRNA) announced today that its investigational H5 avian influenza vaccine, mRNA-1018, has shown ...

The FDA has approved Moderna’s new Covid-19 vaccine, though it placed restrictions on its use that the company’s existing ...

We recently published a list of Jim Cramer Talked About These 13 Stocks. In this article, we are going to take a look at ...